Holders — by stockHoldings — by fund
St. James Investment Company, LLC
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-06-30 · filed with the SEC up to 45 days after quarter end · CIK 1504492
$629.8M
disclosed book value
24
positions
13.7%
largest position share
Positions, as of 2026-06-30
top 24 of 24 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | GBILGOLDMAN SACHS ETF TR | 861,962 | $86.3M | 13.7% |
| 2 | BRK/BBERKSHIRE HATHAWAY INC DEL | 146,051 | $73.1M | 11.6% |
| 3 | LLOEWS CORP | 451,300 | $51.1M | 8.1% |
| 4 | FNVFRANCO NEV CORP | 215,769 | $45.0M | 7.1% |
| 5 | ULUNILEVER PLC | 710,415 | $42.7M | 6.8% |
| 6 | MEDTRONIC PLC | 419,227 | $32.8M | 5.2% |
| 7 | VZVERIZON COMMUNICATIONS INC | 737,259 | $31.2M | 5% |
| 8 | OKEONEOK INC NEW | 354,688 | $30.8M | 4.9% |
| 9 | RYNRAYONIER INC | 1.3M | $27.5M | 4.4% |
| 10 | EOGEOG RES INC | 204,570 | $26.5M | 4.2% |
| 11 | HUBBHUBBELL INC | 48,418 | $25.3M | 4% |
| 12 | APDAIR PRODUCTS AND CHEMICALS I | 72,303 | $21.2M | 3.4% |
| 13 | TRVTRAVELERS COMPANIES INC | 62,212 | $20.5M | 3.3% |
| 14 | NEENEXTERA ENERGY INC | 230,853 | $20.3M | 3.2% |
| 15 | IEXIDEX CORP | 88,158 | $20.0M | 3.2% |
| 16 | EMREMERSON ELEC CO | 121,969 | $17.5M | 2.8% |
| 17 | AEMAGNICO EAGLE MINES LTD | 111,548 | $17.3M | 2.7% |
| 18 | HONHONEYWELL INTL INC | 53,815 | $12.5M | 2% |
| 19 | ABEQUNIFIED SER TR | 300,070 | $11.2M | 1.8% |
| 20 | HONAHONEYWELL AEROSPACE INC | 46,139 | $10.2M | 1.6% |
| 21 | SHYISHARES TR | 27,518 | $2.3M | 0.4% |
| 22 | PHYSSPROTT ASSET MANAGEMENT LP | 62,280 | $1.9M | 0.3% |
| 23 | CEFSPROTT ASSET MANAGEMENT LP | 41,556 | $1.7M | 0.3% |
| 24 | PEOADAM NAT RES FD INC | 37,130 | $917,854 | 0.1% |
Source: SEC Form 13F-HR, reporting period 2026-06-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.